Evidence map›Paper›PMID 21334141›Full record

ArticleBurns : journal of the International Society for Burn Injuries2011

Mechanistic aspects of inducible nitric oxide synthase-induced lung injury in burn trauma.

Perenlei Enkhbaatar, Jianpu Wang, Fiona Saunders, Matthias Lange, Atsumori Hamahata, Sebastian Rehberg, John F Parkinson, Lillian D Traber, David N Herndon, Daniel L Traber

Abstract read
In one paragraph

Article in Burns : journal of the International Society for Burn Injuries, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Emerging therapies for smoke inhalation injury: a review.Journal of translational medicine · 2020
    Review
  2. Article
  3. Article
  4. OXIDATIVE STRESS IN A RAT MODEL OF COTTON SMOKE INHALATION-INDUCED PULMONARY INJURY.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2016
    Article
  5. Effects of basic drugs on prognosis of acute lung injury in mice.International journal of clinical and experimental medicine · 2015
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Perenlei EnkhbaatarDepartment of Anesthesiology, The University of Texas Medical Branch, Galveston, TX, USA. peenkhba@utmb.edu
Jianpu Wang
Fiona Saunders
Matthias Lange
Atsumori Hamahata
Sebastian Rehberg
John F Parkinson
Lillian D Traber
David N Herndon
Daniel L Traber
The University of Texas Medical Branch at Galveston · USBayer (United States) · USShriners Hospitals for Children - Galveston · US

Funding

Role of Ventilator Damage Inflammation in Burn and Inhalation Injury/Project 4P01GM066312 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI TRABER, DANIEL L · 2004 to 2009
$7.9M
THE ROLE OF SELECTINS IN BURNS AND INHALATION INJURYR01GM060688 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI TRABER, DANIEL L · 2000 to 2009
$2.6M
NIGMS NIH HHS P01 GM066312NIGMS NIH HHS R01 GM060688
6 · The paper itself

Abstract

introductionAlthough the beneficial effects of inducible nitric oxide synthase (iNOS) inhibition in acute lung injury secondary to cutaneous burn and smoke inhalation were previously demonstrated, the mechanistic aspects are not completely understood. The objective of the present study is to describe the mechanism(s) underlying these favourable effects. We hypothesised that iNOS inhibition prevents formation of excessive reactive nitrogen species and attenuates the activation of poly(ADP) (poly(adenosine diphosphate)) ribose polymerase, thus mitigating the severity of acute lung injury in sheep subjected to combined burn and smoke inhalation.

methodsAdult ewes were chronically instrumented for a 24-h study and allocated to groups: sham: not injured, not treated, n = 6; control: injured, not treated, n = 6; and BBS-2: injured treated with iNOS dimerisation inhibitor BBS-2, n = 6. Control and BBS-2 groups received 40% total body surface area 3rd-degree cutaneous burn and cotton smoke insufflation into the lungs under isoflurane anaesthesia.

resultsTreatment with iNOS inhibitor BBS-2 significantly improved pulmonary gas exchange (partial pressure of oxygen in the blood/fraction of inspired oxygen (PaO₂/FiO₂) 409 ± 43 mmHg vs. 233 ± 50 mmHg in controls, p < 0.05) and reduced airway pressures (peak pressure 20 ± 1 cm H₂O vs. 28 ± 2 cm H₂O in controls, p < 0.05) and lung water content (lung wet-to-dry ratio 4.1 ± 0.3 vs. 5.2 ± 0.2 in controls, p < 0.05) 24h after the burn and smoke injury. BBS-2 significantly reduced the increases in lung lymph nitrite/nitrate (10 ± 3 μM vs. 26 ± 6 μM in controls, p < 0.05) and 3-nitrotyrosine (109 ± 11 (densitometry value) vs. 151 ± 18 in controls, p < 0.05). Burn/smoke-induced increases in lung tissue nitrite/nitrate, poly(ADP)ribose polymerase, nuclear factor-κB (NF-κB) activity, myeloperoxidase activity and malondialdehyde formation and interleukin (IL)-8 expression were also attenuated with BBS-2.

conclusionsThe results provide strong evidence that BBS-2 ameliorated acute lung injury by inhibiting the inducible nitric oxide synthase/reactive nitrogen species/poly(ADP-ribose) polymerase (iNOS/RNS/PARP) pathway.

Indexed as

Analysis of VarianceAnimalsBurnsDisease Models, AnimalFemaleImidazolesImmunohistochemistryInterleukin-8LungMalondialdehydeNF-kappa BNitric Oxide Synthase Type IIPeroxidasePiperazinesPulmonary Gas ExchangePyrimidines3-nitrotyrosineImidazolesInterleukin-8MalondialdehydeN-((1,3-benzodioxol-5-yl)methyl)-1-(2-(1H-imidazol-1-yl)pyrimidin-4-yl)-4-(methoxycarbonyl)piperazine-2-acetamideNF-kappa BNitric Oxide Synthase Type IIPeroxidasePiperazinesPyrimidinesRNA, MessengerTyrosine

Identifiers

PMID21334141
PMCPMC3936245
OpenAlexW2168543327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.